Results 1 to 10 of about 44,761 (349)

Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study [PDF]

BMJ Open, 2021
Objective To assess the 5-year changes in the adult medical use of central nervous system (CNS) stimulants with higher risk of dependence and evaluate the population characteristics of users and their medical and/or neurological conditions.Design Cross ...
G Caleb Alexander, Thomas J Moore, Stefan P Kruszewski, Phillip W Wirtz   +3 more
doaj   +4 more sources

Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis [PDF]

BMJ Open, 2023
Objective Examine patterns of adult medical use of amphetamine and methylphenidate stimulant drugs, classified in the USA as Schedule II controlled substances with a high potential for psychological or physical dependence.Design Cross-sectional study ...
G Caleb Alexander, Thomas J Moore, Phillip W Wirtz, Jill N Curran   +3 more
doaj   +4 more sources

Central nervous system stimulants and sport practice. [PDF]

Br J Sports Med, 2006
Background and objectives:Central nervous system (CNS) stimulants may be used to reduce tiredness and increase alertness, competitiveness, and aggression. They are more likely to be used in competition but may be used during training to increase the intensity of the training session. There are several potential dangers involving their misuse in contact
Avois L, Robinson N, Saudan C, Baume N, Mangin P, Saugy M.   +5 more
europepmc   +6 more sources

Opinion and prevalence of use of central nervous system stimulants in open population: results of an electronic survey [PDF]

Revista Mexicana de Neurociencia, 2022
Objective: The objective of the study was to know the opinion and prevalence of use of central nervous system stimulant drugs (SDs) in healthy people in open population.
Paulina Flores-Medina, Paul Carrillo-Mora   +1 more
doaj   +2 more sources

Nitric oxide and cytokine production by glial cells exposed in vitro to neuropathogenic schistosome Trichobilharzia regenti [PDF]

Parasites & Vectors, 2016
Background Helminth neuroinfections represent a serious health problem, but host immune mechanisms in the nervous tissue often remain undiscovered. This study aims at in vitro characterization of the response of murine astrocytes and microglia exposed to
Tomáš Macháček, Lucie Panská, Hana Dvořáková, Petr Horák   +3 more
doaj   +2 more sources

Central Nervous System Stimulants Limit Caffeine Transport at the Blood-Cerebrospinal Fluid Barrier. [PDF]

Int J Mol Sci, 2022
Ikeda-Murakami K, Tani N, Ikeda T, Aoki Y, Ishikawa T.   +4 more
europepmc   +3 more sources

The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV [PDF]

Addiction Science & Clinical Practice
Background Drug-related mortality in the United States continues to transform, marked by a surge in overdose deaths involving both fentanyl and stimulants.
Ayesha Appa, Xochitl Luna Marti, Stefan Baral, Steven Shoptaw, Alexander R. Bazazi, Matthew A. Spinelli, Dave Glidden, Monica Gandhi, Phillip Coffin   +8 more
doaj   +2 more sources

Consumption of Central Nervous System Stimulants among Medical and Nursing Students at a Chilean University

SMAD: Revista Eletrônica Saúde Mental Álcool e Drogas, 2013
El estudio objetivó determinar la prevalencia de consumo de psicoestimulantes, en estudiantes de enfermería y medicina de una universidad chilena, las características personales y motivaciones para lo consumo de estas sustancias.
Carmen Gloria-Garcés, Kelly Graziani Giacchero Vedana   +1 more
doaj   +1 more source

The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School. [PDF]

J Child Adolesc Psychopharmacol, 2016
Baweja R, Belin PJ, Humphrey HH, Babocsai L, Pariseau ME, Waschbusch DA, Hoffman MT, Akinnusi OO, Haak JL, Pelham WE, Waxmonsky JG.   +10 more
europepmc   +2 more sources

Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder. [PDF]

J Pediatr, 2022
Waxmonsky JG, Pelham WE, Baweja R, Hale D, Pelham WE.   +4 more
europepmc   +3 more sources